Acutus Medical to Announce Second Quarter 2021 Financial Results

Rhea-AI Summary

Acutus Medical, a company specializing in arrhythmia management, will release its financial results for Q2 2021 on August 12, 2021. A conference call will follow at 1:30 PM PT / 4:30 PM ET to discuss these results and recent highlights. Acutus aims to transform the diagnosis and treatment of cardiac arrhythmias through innovative products and technologies, enhancing the efficiency of healthcare providers. Founded in 2011 and based in Carlsbad, California, the company continues to expand its global sales presence.

Positive

• Upcoming Q2 2021 financial results may show significant advancements in revenue.
• The planned conference call provides transparency and updates for investors.

Negative

• None.

CARLSBAD, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today it will release its financial results for the second quarter of 2021 on Thursday, August 12, 2021. In conjunction with the release, Acutus will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 8377418. The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website following the earnings call.

About Acutus Medical
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-202-5678
caroline.corner@westwicke.com

Holly Windler
M: 619-929-1275
media@acutusmedical.com

FAQ

When will Acutus Medical release its financial results for Q2 2021?

Acutus Medical will release its financial results for Q2 2021 on August 12, 2021.

What time is the conference call for Acutus Medical's Q2 2021 results?

The conference call is scheduled for 1:30 PM Pacific Time / 4:30 PM Eastern Time on August 12, 2021.

How can I access Acutus Medical's conference call?

The conference call can be accessed via telephone at (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 8377418.

What is Acutus Medical's focus in the healthcare sector?

Acutus Medical focuses on improving the diagnosis and treatment of cardiac arrhythmias through innovative electrophysiology products and technologies.